Variable | Enterobacter SBP (n = 32) | E. coli SBP (n = 128) | P |
---|---|---|---|
Initial clinical manifestation, n (%) | |||
 Abdominal pain | 23 (71.9) | 90 (70.3) | 0.86 |
 Fever | 24 (75.0) | 87 (68.0) | 0.44 |
 Hepatic encephalopathy | 6 (18.8) | 34 (26.6) | 0.36 |
 Septic shock | 5 (15.6) | 31 (24.2) | 0.30 |
Upper gastrointestinal bleeding, n (%) | 9 (28.1) | 12 (9.4) | 0.005 |
 Variceal bleeding | 7 | 11 |  |
 Ulcer bleeding | 1 | 1 |  |
 Duodenal invasion of cancer | 1 | 0 |  |
Concomitant bacteremia, n (%) | 11 (34.4) | 87 (68.0) | 0.001 |
Laboratory finding, median (IQR) | |||
 Serum WBC, cells/μL | 8,050 (5,125 − 13,200) | 6,450 (4,400 − 9,675) | 0.12 |
 Platelets, x 10/mL | 61 (44–104) | 62 (41–85) | 0.15 |
 C-reactive protein, mg/dL | 6.41 (2.1–7.9) | 3.06 (1.1–6.2) | 0.06 |
 Serum creatinine, mg/dL | 1.2 (0.9–1.5) | 1.2 (0.9–1.7) | 0.80 |
 Serum bilirubin, mg/dL | 3.8 (2.6–12.2) | 5.3 (3.5–10.3) | 0.79 |
 Ascites WBC, cells/μL | 6,160 (1,945–11,795) | 5,360 (2,690–11,960) | 0.45 |
 Ascites neutrophils, cells/μL | 5,058 (1,483–10,899) | 4,275 (2,092–10,771) | 0.46 |
Ascites protein, mg/dL | 1.5 (1.0–2.5) | 1.0 (0.8–1.4) | 0.003 |